Danuta Zatorska

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

11h-index1.1kcitations36works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(15), Radiopharmaceutical Chemistry and Applications(15), Heat shock proteins research(13), Radiomics and Machine Learning in Medical Imaging(12), Computational Drug Discovery Methods(6)

Publications36 total

Supplementary Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplementary Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 4 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 5 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 3 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 2 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 4 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 2 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 1 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 5 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Supplemental Figure 3 from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
2023Open Access
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
Nature Communications·2021· 33 citedOpen Access
First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
Clinical Cancer Research·2020· 29 citedOpen Access
Radiosynthesis of the iodine‐124 labeled Hsp90 inhibitor PU‐H71
Journal of Labelled Compounds and Radiopharmaceuticals·2016· 24 citedOpen Access
ChemInform Abstract: Preparation of a Diverse Purine‐Scaffold Library via One‐Step Palladium Catalyzed Cross‐Coupling.
ChemInform·2013
Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes
Beilstein Journal of Organic Chemistry·2013· 16 citedOpen Access
Preparation of a Diverse Purine-Scaffold Library via One-Step Palladium Catalyzed Cross-Coupling
Heterocycles·2012· 5 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Gabriela Chiosis(33), Tony Taldone(30), Jason S. Lewis(22), Nagavarakishore Pillarsetty(20), Steven M. Larson(20), Stefan O. Ochiana(17), Pat Zanzonico(17), Mark Dunphy(17), Serge K. Lyashchenko(16), Eva Burnazi(16), Milan Grkovski(16), Bradley J. Beattie(16), Christina Pressl(15), Shanu Modi(15), Komal Jhaveri(15), Larry Norton(15), Mohammad M. Uddin(15), Clifford A. Hudis(15), Jacqueline Bromberg(15), Heiko Schöder(15)